RBC Capital Cuts Acadia Healthcare (ACHC) PT to $28 Despite Strong Q2 Revenue Growth

Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the best small cap stocks with biggest upside potential. On August 13, RBC Capital analyst Ben Hendrix lowered the firm’s price target on Acadia Healthcare to $28 from $43, while keeping an Outperform rating on the shares after the company’s Q2 2025 results were announced.

Acadia Healthcare Company reported that its revenue increased by 9.2% year-over-year in Q2 to $869.2 million. This growth was driven by a 9.5% increase in same-facility revenue, which included a 7.5% rise in revenue per patient day and a 1.8% increase in patient days. While net income attributable to Acadia was $30.1 million, or $0.33 per diluted share, this figure was impacted by several one-time items.

RBC Capital Cuts Acadia Healthcare (ACHC) PT $28 Despite Strong Q2 Revenue Growth

A healthcare professional discussing a treatment plan with a patient in an outpatient clinic.

Acadia added 101 new licensed beds to existing facilities in this quarter. This brought the total beds added in H1 to 479, which included 288 beds in newly constructed facilities. Additionally, Acadia added 4 new comprehensive treatment centers/CTCs, extending its network to 174 CTCs across 33 states and serving over 74,000 patients daily.

Acadia Healthcare Company Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the US and Puerto Rico.

While we acknowledge the potential of ACHC to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ACHC and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.